Cold plasma successful against brain cancer cells, study suggests
If someone is diagnosed with the type of brain tumour called glioblastoma, the prospects are dire: median survival is just a bit over one year, and less than 16 % of the patients survive more than three years. It is still unknown how this cancer is triggered — only a few rare genetic factors have been identified so far — and treatment remains largely palliative, i.e. trying to alleviate the symptoms and prolonging the life of the patient. …